Masimo Corporation $MASI Position Increased by Geode Capital Management LLC

Geode Capital Management LLC raised its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 1.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 953,976 shares of the medical equipment provider’s stock after buying an additional 11,537 shares during the period. Geode Capital Management LLC’s holdings in Masimo were worth $124,096,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Global Retirement Partners LLC bought a new stake in Masimo during the fourth quarter worth approximately $27,000. Torren Management LLC bought a new stake in Masimo during the fourth quarter worth approximately $35,000. Smartleaf Asset Management LLC boosted its holdings in Masimo by 80.0% during the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 136 shares in the last quarter. Advisory Services Network LLC bought a new stake in Masimo during the third quarter worth approximately $46,000. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in Masimo during the fourth quarter worth approximately $44,000. 85.96% of the stock is currently owned by institutional investors.

Masimo Trading Down 0.0%

Masimo stock opened at $178.82 on Friday. The company has a 50 day moving average price of $178.45 and a 200 day moving average price of $159.32. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $179.00. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. The firm has a market capitalization of $9.36 billion, a price-to-earnings ratio of -16.97, a P/E/G ratio of 1.81 and a beta of 1.11.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on MASI. Piper Sandler cut shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a report on Tuesday, February 17th. Raymond James Financial cut shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a report on Tuesday, February 17th. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Finally, BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Nine research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $180.40.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.